VERA Q1 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$57M

Net Income

-$52M

EPS (Diluted)

$-0.81

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$610M

Total Liabilities

$75M

Stockholders' Equity

$535M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$952,000	-100.0%
Operating Income	-$57M	-$31M	-83.8%
Net Income	-$52M	-$28M	-82.1%